生検装置市場：製品、技術、用途、エンドユーザー別-2025～2030年の世界予測

生検装置市場は、2023年に94億7,000万米ドルと評価され、2024年には104億6,000万米ドルに達すると予測され、CAGR 10.82%で成長し、2030年には194億6,000万米ドルに達すると予測されています。

生検装置は、検査のために細胞や組織サンプルを抽出するために使用される重要な診断ツールであり、通常、がん、感染症、炎症状態を検出するために使用されます。これらのデバイスの必要性は、早期診断を容易にし、精密治療を可能にし、それによって患者の転帰を向上させるという重要な役割に由来します。生検装置の用途は、腫瘍学、婦人科学、泌尿器学など多岐にわたります。低侵襲技術の出現により、外来患者での活用が増加しています。最終用途は主に病院、診断センター、研究機関などです。市場成長は、がんや慢性疾患の有病率の上昇、生検技術の技術的進歩、低侵襲手技の需要増加などの要因に大きく影響されます。新興国市場と医療支出の増加は、特に医療インフラが拡大しつつある発展途上地域に十分な機会をもたらしています。戦略的な推奨事項としては、よりポータブルでユーザーフレンドリーな機器の開発に投資すること、より優れたデータ分析と患者モニタリングのためにデジタルソリューションとの統合に注力すること、製品革新のための共同研究を促進することなどが挙げられます。逆に、先進的生検装置に関連する高コストや厳しい規制要件は大きな制約となり、熟練した専門家の不足や手技に伴うリスクなどの課題は市場浸透に影響を与えます。技術革新の主要開発セグメントとしては、ロボット支援型生検装置の開発、精度向上のための画像処理技術の強化、在宅診断を容易にするウェアラブル生検ツールの開発などが挙げられます。さらに、効率性を高め、人的ミスを減らすための生検採取とサンプル分析の自動化に焦点を当てた調査も可能です。このような力学を理解することで、生検装置市場がより技術主導のエコシステムへと移行しつつあり、研究開発への投資拡大やユーザー中心のソリューションへの注力が市場拡大の起爆剤となり、大きなビジネス成長機会を提供できることが明らかになります。

市場力学：急速に進化する生検装置市場の主要市場洞察を公開

生検装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんと消化器疾患の増加
  • 低侵襲技術の採用の増加
  • 疾患の早期発見とスクリーニングの重要性に対する意識の高まり
• 市場抑制要因
  • 生検装置の生産に伴う高コスト
• 市場機会
  • 生検装置の絶え間ない技術進歩
  • 液体生検装置への傾斜の高まり
• 市場課題
  • 保健当局による厳しい規制に伴う問題

ポーターのファイブフォース：生検装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、生検装置市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生検装置市場における外部からの影響の把握

外部マクロ環境要因は、生検装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：生検装置市場における競合情勢の把握

生検装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：生検装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生検装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや胃腸疾患の発生率増加
    • 低侵襲技術の採用の増加
    • 病気の早期発見とスクリーニングの重要性に対する認識の高まり
  • 抑制要因
    • 生検装置の制作にかかるコストが高い
  • 機会
    • 生検装置における継続的な技術進歩
    • 流動性への傾向の高まり生検装置
  • 課題
    • 保健当局による厳格な規制に伴う問題
• 市場セグメンテーション分析
  • 製品：合併症のリスクが最小限であるため、針ベースの生検器具が好まれる傾向が高まっている
  • 技術：高い診断精度を実現する生検装置におけるMRI誘導生検の重要な役割
  • 用途：乳がんと前立腺がんの両方の症例が増加しているため、乳がんと前立腺がんの需要が高まっている
  • エンドユーザー：病院での回復時間の短縮を促進する生検装置の利用率の向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 生検装置市場：製品別

• イントロダクション
• 生検鉗子
• 局所ワイヤ
• 針式生検器具
  • 吸引針
  • コア生検装置
  • 真空補助型生検装置
• 処置トレイ

第7章 生検装置市場：技術別

• イントロダクション
• 画像誘導生検
  • MRIガイド下生検
  • 定位ガイド下生検
  • 超音波ガイド下生検
• 非画像誘導生検

第8章 生検装置市場：用途別

• イントロダクション
• 骨髄生検
• 乳房生検
• 腎臓生検
• 肺生検
• 前立腺生検

第9章 生検装置市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 診断・画像診断センター
• 病院

第10章 南北アメリカの生検装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の生検装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの生検装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • LUMINELLE、中国国家知識産権局によるLUMINELLE Bx（生検）システムの特許発行決定を発表、世界展開を拡大
  • Limaca Medical、画期的な精密消化管内視鏡生検装置でFDA 510（k）認可を取得
  • Stryker、頭蓋誘導ソフトウェアを搭載したQガイダンスシステムの商業発売を発表
  • Merit Medical、アンジオ力学のカテーテルポートフォリオと生検システムを買収
  • ArgonのSuperCore Advantage生検装置が米国で発売
  • Quest DiagnosticsがHaystack Oncologyを買収、腫瘍学ポートフォリオに個別化がん治療の改善に向けた高感度液体生検技術を追加
  • Innovia MedicalがBACO Internationalで口腔回転式生検パンチを発表
  • Guardant360 CDxがORSERDUのコンパニオン診断薬としてFDAの承認を取得
  • TransMed7 LLC、SpeedBird Breast生検装置の商業発売に向けた初の臨床使用を発表
  • Terumo India、ポートフォリオ拡大のためArgon Medicalと提携

企業一覧

• Integra LifeSciences Holdings Corporation
• F. Hoffmann-La Roche Ltd.
• Stryker Corporation
• CONMED Corporation
• Danaher Corporation
• Innovia Medical
• Remington Medical
• Spectra Medical Devices, LLC
• PAJUNK GmbH Medizintechnologie
• Cardinal Health, Inc.
• Argon Medical Devices, Inc.
• Medtronic PLC
• B. Braun SE
• Advin Health Care
• Fujifilm Holdings Corporation
• MediTech Devices Pvt Ltd.
• Suretech Medical Inc.
• Olympus Corporation
• Trajan Scientific and Medical Pty Ltd.
• Merit Medical Systems, Inc.
• TSK Laboratory
• Axlab Limited
• Ferrosan Medical Devices A/S
• UVision360
• INRAD, Inc.
• Volkmann MedizinTechnik GmbH
• JEB Technologies Limited
• Guardant Health, Inc.
• IZI Medical Products, LLC by Halma PLC
• Zamar Care
• Mermaid Medical
• Limaca-Medical
• Cook Group Incorporated
• Hologic, Inc.
• Becton, Dickinson and Company
• weLLgo Medical Products GmbH
• Boston Scientific Corporation
• TransMed7, LLC

LIST OF FIGURES

• FIGURE 1. BIOPSY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPSY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BIOPSY FORCEPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOPSY DEVICES MARKET SIZE, BY NON-IMAGE GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BONE MARROW BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. CANADA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. CHINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. CHINA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. CHINA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 88. CHINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. CHINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. INDIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. INDIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 92. INDIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 94. INDIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. ITALY BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. ITALY BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 195. ITALY BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 197. ITALY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. ITALY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. POLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. POLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 219. POLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 221. POLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. POLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. QATAR BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. QATAR BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. QATAR BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 227. QATAR BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. QATAR BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY IMAGE GUIDED BIOPSY, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Biopsy Devices Market was valued at USD 9.47 billion in 2023, expected to reach USD 10.46 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 19.46 billion by 2030.

Biopsy devices are crucial diagnostic tools employed to extract cells or tissue samples for examination, typically to detect cancer, infections, or inflammatory conditions. The necessity for these devices stems from their vital role in facilitating early diagnosis and enabling precision treatment, thereby enhancing patient outcomes. Applications of biopsy devices span across oncology, gynecology, urology, and more. They are increasingly leveraged in outpatient settings due to the advent of minimally invasive techniques. End-use sectors primarily include hospitals, diagnostic centers, and research institutes. Market growth is significantly influenced by factors such as the rising prevalence of cancer and chronic diseases, technological advancements in biopsy techniques, and increasing demand for minimally invasive procedures. Emerging markets and increasing healthcare expenditure further present ample opportunities, particularly in developing regions where healthcare infrastructure is expanding. Strategic recommendations include investing in the development of more portable and user-friendly devices, focusing on integration with digital solutions for better data analytics and patient monitoring, and fostering collaborations for product innovations. Conversely, high costs associated with advanced biopsy devices and stringent regulatory requirements pose significant limitations, while challenges such as the lack of skilled professionals and procedure-associated risks affect market penetration. Key areas for innovation include the development of robotics-assisted biopsy devices, enhanced imaging technologies to improve precision, and wearable biopsy tools to facilitate at-home diagnostics. Additionally, research can focus on automation in biopsy collection and sample analysis for enhanced efficiency and reduced human errors. Understanding these dynamics reveals that the biopsy devices market is transitioning towards a more technology-driven ecosystem, where increased investment in R&D and a focus on user-centric solutions can catalyze market expansion and offer substantial business growth opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopsy Devices Market

The Biopsy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidences of cancer and gastrointestinal diseases
  • Rise in adoption of minimally-invasive techniques
  • Increasing awareness of the importance of early detection and screening of diseases
• Market Restraints
  • High cost associated with the production of biopsy devices
• Market Opportunities
  • Continuous technological advancements in biopsy devices
  • Growing inclination towards liquid biopsy devices
• Market Challenges
  • Problems associated with stringent regulations by health authorities

Porter's Five Forces: A Strategic Tool for Navigating the Biopsy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopsy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopsy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopsy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopsy Devices Market

A detailed market share analysis in the Biopsy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopsy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopsy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Integra LifeSciences Holdings Corporation, F. Hoffmann-La Roche Ltd., Stryker Corporation, CONMED Corporation, Danaher Corporation, Innovia Medical, Remington Medical, Spectra Medical Devices, LLC, PAJUNK GmbH Medizintechnologie, Cardinal Health, Inc., Argon Medical Devices, Inc., Medtronic PLC, B. Braun SE, Advin Health Care, Fujifilm Holdings Corporation, MediTech Devices Pvt Ltd., Suretech Medical Inc., Olympus Corporation, Trajan Scientific and Medical Pty Ltd., Merit Medical Systems, Inc., TSK Laboratory, Axlab Limited, Ferrosan Medical Devices A/S, UVision360, INRAD, Inc., Volkmann MedizinTechnik GmbH, JEB Technologies Limited, Guardant Health, Inc., IZI Medical Products, LLC by Halma PLC, Zamar Care, Mermaid Medical, Limaca-Medical, Cook Group Incorporated, Hologic, Inc., Becton, Dickinson and Company, weLLgo Medical Products GmbH, Boston Scientific Corporation, and TransMed7, LLC.

Market Segmentation & Coverage

This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biopsy Forceps, Localization Wires, Needle-Based Biopsy Instruments, and Procedure Trays. The Needle-Based Biopsy Instruments is further studied across Aspiration Needles, Core Biopsy Devices, and Vacuum-Assisted Biopsy Devices.
• Based on Technique, market is studied across Image Guided Biopsy and Non-Image Guided Biopsy. The Image Guided Biopsy is further studied across MRI-Guided Biopsy, Stereotactic-Guided Biopsy, and Ultrasound-Guided Biopsy.
• Based on Application, market is studied across Bone Marrow Biopsy, Breast Biopsy, Kidney Biopsy, Lung Biopsy, and Prostate Biopsy.
• Based on End User, market is studied across Academic & Research Institutes, Diagnostic & Imaging Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of cancer and gastrointestinal diseases
    • 5.1.1.2. Rise in adoption of minimally-invasive techniques
    • 5.1.1.3. Increasing awareness of the importance of early detection and screening of diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of biopsy devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous technological advancements in biopsy devices
    • 5.1.3.2. Growing inclination towards liquid biopsy devices
  • 5.1.4. Challenges
    • 5.1.4.1. Problems associated with stringent regulations by health authorities
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
  • 5.2.2. Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
  • 5.2.3. Application: Growing need for breast and prostate biopsy devices due to increasing instances of cancer in both areas
  • 5.2.4. End User: Rising utilization of biopsy devices that promote lesser recovery time in the hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopsy Devices Market, by Product

• 6.1. Introduction
• 6.2. Biopsy Forceps
• 6.3. Localization Wires
• 6.4. Needle-Based Biopsy Instruments
  • 6.4.1. Aspiration Needles
  • 6.4.2. Core Biopsy Devices
  • 6.4.3. Vacuum-Assisted Biopsy Devices
• 6.5. Procedure Trays

7. Biopsy Devices Market, by Technique

• 7.1. Introduction
• 7.2. Image Guided Biopsy
  • 7.2.1. MRI-Guided Biopsy
  • 7.2.2. Stereotactic-Guided Biopsy
  • 7.2.3. Ultrasound-Guided Biopsy
• 7.3. Non-Image Guided Biopsy

8. Biopsy Devices Market, by Application

• 8.1. Introduction
• 8.2. Bone Marrow Biopsy
• 8.3. Breast Biopsy
• 8.4. Kidney Biopsy
• 8.5. Lung Biopsy
• 8.6. Prostate Biopsy

9. Biopsy Devices Market, by End User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Diagnostic & Imaging Centers
• 9.4. Hospitals

10. Americas Biopsy Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biopsy Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biopsy Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. LUMINELLE Announces China National Intellectual Property Administration's Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
  • 13.3.2. Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
  • 13.3.3. Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
  • 13.3.4. Merit Medical Acquires AngioDynamics' Catheter Portfolio and Biopsy System
  • 13.3.5. Argon's SuperCore Advantage Biopsy Instrument Launched in United States
  • 13.3.6. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
  • 13.3.7. Innovia Medical Launches the Oral Rotating Biopsy Punch at BACO International 2023
  • 13.3.8. Guardant360 CDx Gets FDA Approval as Companion Diagnostic for ORSERDU
  • 13.3.9. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
  • 13.3.10. Terumo India Partners with Argon Medical to Expand Portfolio

Companies Mentioned

• 1. Integra LifeSciences Holdings Corporation
• 2. F. Hoffmann-La Roche Ltd.
• 3. Stryker Corporation
• 4. CONMED Corporation
• 5. Danaher Corporation
• 6. Innovia Medical
• 7. Remington Medical
• 8. Spectra Medical Devices, LLC
• 9. PAJUNK GmbH Medizintechnologie
• 10. Cardinal Health, Inc.
• 11. Argon Medical Devices, Inc.
• 12. Medtronic PLC
• 13. B. Braun SE
• 14. Advin Health Care
• 15. Fujifilm Holdings Corporation
• 16. MediTech Devices Pvt Ltd.
• 17. Suretech Medical Inc.
• 18. Olympus Corporation
• 19. Trajan Scientific and Medical Pty Ltd.
• 20. Merit Medical Systems, Inc.
• 21. TSK Laboratory
• 22. Axlab Limited
• 23. Ferrosan Medical Devices A/S
• 24. UVision360
• 25. INRAD, Inc.
• 26. Volkmann MedizinTechnik GmbH
• 27. JEB Technologies Limited
• 28. Guardant Health, Inc.
• 29. IZI Medical Products, LLC by Halma PLC
• 30. Zamar Care
• 31. Mermaid Medical
• 32. Limaca-Medical
• 33. Cook Group Incorporated
• 34. Hologic, Inc.
• 35. Becton, Dickinson and Company
• 36. weLLgo Medical Products GmbH
• 37. Boston Scientific Corporation
• 38. TransMed7, LLC